February 2003

Products, Services, and Literature logo in a gray background | Products, Services, and Literature
Business
Products, Services, and Literature February 2003Products, Services, and Literature February 2003
Products, Services, and Literature
Feb 1, 2003
byBPI Contributor
Conferences, Courses, and Events logo in a gray background | Conferences, Courses, and Events
Business
Conferences, Courses, and Events February 2003Conferences, Courses, and Events February 2003
Conferences, Courses, and Events
Feb 1, 2003
byBPI Contributor
Big Pharma Talks Back logo in a gray background | Big Pharma Talks Back
Economics
Big Pharma Talks BackBig Pharma Talks Back
Big Pharma Talks Back
Feb 1, 2003
byBPI Contributor
Web Services Architecture logo in a gray background | Web Services Architecture
Information Technology
Web Services ArchitectureWeb Services Architecture
Web Services Architecture
Feb 1, 2003
byBPI Contributor
So What Are GMPs, Anyway? logo in a gray background | So What Are GMPs, Anyway?
Regulatory Affairs
So What Are GMPs, Anyway?So What Are GMPs, Anyway?
So What Are GMPs, Anyway?
Feb 1, 2003
byBPI Contributor
Quantity In, Quality Out logo in a gray background | Quantity In, Quality Out
Economics
Quantity In, Quality OutQuantity In, Quality Out
Quantity In, Quality Out
Feb 1, 2003
byBPI Contributor
Glossary of International Biotherapeutic Regulation logo in a gray background | Glossary of International Biotherapeutic Regulation
Regulatory Affairs
Glossary of International Biotherapeutic RegulationGlossary of International Biotherapeutic Regulation
Glossary of International Biotherapeutic Regulation
Feb 1, 2003
byBPI Contributor
Three Activity-Based Assays for Serp-1 logo in a gray background | Three Activity-Based Assays for Serp-1
Assays
Three Activity-Based Assays for Serp-1Three Activity-Based Assays for Serp-1
Three Activity-Based Assays for Serp-1
Feb 1, 2003
byBPI Contributor
The Case for Serum-Free Media logo in a gray background | The Case for Serum-Free Media
Cell Culture Media
The Case for Serum-Free MediaThe Case for Serum-Free Media
The Case for Serum-Free Media
Feb 1, 2003
byBPI Contributor
Structural Signatures for Analysis and Characterization of Biological Products logo in a gray background | Structural Signatures for Analysis and Characterization of Biological Products
Product Characterization
Structural Signatures for Analysis and Characterization of Biological ProductsStructural Signatures for Analysis and Characterization of Biological Products
Structural Signatures for Analysis and Characterization of Biological Products
Feb 1, 2003
byBPI Contributor

Webinars

Ask the Expert webcasts
ATE Webcasts
Register Now: Evaluation of a New Multimodal Anion Exchange Resin for Emerging Biotherapeutic Process Challenges
Register Now: Evaluation of a New Multimodal Anion Exchange Resin for Emerging Biotherapeutic Process Challenges
Ask the Expert webcasts
ATE Webcasts
Register Now: Linking mAb Product Quality Profile Changes to Your Bioprocess: Case Study of Dynamic Glucose Level Control in CHO Process Improves Product Quality
Register Now: Linking mAb Product Quality Profile Changes to Your Bioprocess: Case Study of Dynamic Glucose Level Control in CHO Process Improves Product Quality
Ask the Expert webcasts
ATE Webcasts
Register Now: Navigating Biopharma Commercialization: The Interplay of Regulatory Affairs, Process Development, and Manufacturing to Ensure Drug Quality
Register Now: Navigating Biopharma Commercialization: The Interplay of Regulatory Affairs, Process Development, and Manufacturing to Ensure Drug Quality
Insider News
See all
Dec 2 - Dec 5, 2024
The European Cell and Gene Therapy Congress for Groundbreaking Manufacturing, Commercialisation & Analytical Strategies: World renowned leaders share the latest process development, analytical and market access strategies to improve manufacturing scalability, quality and cost to propel your CGT programmes to commercial success
Learn More

Innovative Technology

Emerson white paper
Sponsored Content
Sustainability in Life Sciences: Actionable Solutions for Improving Energy Efficiency
Sustainability in Life Sciences: Actionable Solutions for Improving Energy Efficiency

Nov 12, 2024

WuXi Bio white paper
Sponsored Content
Empowering Modern Drug Product Development: Breakthroughs in High-Concentration Formulations and Drug-Device Combination Products
Empowering Modern Drug Product Development: Breakthroughs in High-Concentration Formulations and Drug-Device Combination Products

Nov 8, 2024

Bora white paper
Sponsored Content
Redefining Scalability: Strategies for Enhancing Early Drug Development to Future-Proof Later Stages
Redefining Scalability: Strategies for Enhancing Early Drug Development to Future-Proof Later Stages

Nov 8, 2024